Mylan Institutional LLC recalls Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only
Recalled August 19, 2015 · FDA recall D-1328-2015 · Mylan Institutional
Hazard
Presence of Particulate Matter · FDA Class I
Units
a) 15,095 vials b) 300 vials
Sold at
Nationwide and Puerto Rico
Description
Presence of Particulate Matter
Product
Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.
Manufacturer(s)
Mylan Institutional LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →